Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/07/08/2909950/0/en/Revolution-Medicines-to-Provide-Update-on-RMC-6236-Pancreatic-Ductal-Adenocarcinoma-Clinical-Program-on-July-15-2024.html
https://www.globenewswire.com/news-release/2024/06/05/2894276/0/en/Revolution-Medicines-to-Participate-in-Goldman-Sachs-45th-Annual-Global-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2024/05/08/2878171/0/en/Revolution-Medicines-Reports-First-Quarter-2024-Financial-Results-and-Update-on-Corporate-Progress.html
https://www.globenewswire.com/news-release/2024/05/01/2873641/0/en/Revolution-Medicines-to-Report-Financial-Results-for-First-Quarter-2024-After-Market-Close-on-May-8-2024.html
https://www.globenewswire.com/news-release/2024/04/09/2860330/0/en/Revolution-Medicines-Announces-Publication-on-the-Discovery-of-and-Translational-Research-for-RMC-6236-an-Investigational-RAS-ON-Multi-Selective-Tri-Complex-Inhibitor-Designed-to-B.html
https://www.globenewswire.com/news-release/2024/04/08/2859370/0/en/Revolution-Medicines-Announces-Publications-on-the-Discovery-and-Preclinical-Profile-of-Representative-of-a-New-Class-of-RAS-ON-Multi-Selective-Inhibitors-Designed-to-Block-Full-Sp.html
https://www.prnewswire.com/news-releases/aethon-therapeutics-announces-collaboration-with-revolution-medicines-to-discover-and-develop-novel-aethon-antibody-programs-302107792.html
https://www.globenewswire.com/news-release/2024/04/04/2858202/0/en/Revolution-Medicines-to-Participate-in-Upcoming-Investor-Conferences.html
https://www.globenewswire.com/news-release/2024/03/28/2854478/0/en/Revolution-Medicines-to-Deliver-Multiple-Presentations-at-the-Upcoming-American-Association-for-Cancer-Research-Annual-Meeting-2024.html
https://www.globenewswire.com//news-release/2024/02/26/2835502/0/en/Revolution-Medicines-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Update-on-Corporate-Progress.html